- Summary
- Actions
- Committee Votes
- Floor Votes
- Memo
- Text
- LFIN
- Chamber Video/Transcript
A02969 Summary:
BILL NO | A02969A |
  | |
SAME AS | SAME AS S02849-A |
  | |
SPONSOR | Peoples-Stokes (MS) |
  | |
COSPNSR | Barrett, Niou, Ortiz, Galef, Abinanti, Lavine, Colton, Jean-Pierre, Taylor, Byrne, Weprin, Seawright, Barron, Mosley, Lupardo, Ashby, Reyes, Rosenthal L, Vanel, Stirpe, Rosenthal D, Griffin, Jaffee, Buchwald, Gottfried, D'Urso, Magnarelli, Stern, Hunter, Jacobson, LiPetri, Hevesi, Otis, Carroll, Steck, Simon, Mikulin, Pichardo, Epstein, Rozic, Wallace, Malliotakis, Buttenschon, Schmitt, Dinowitz, Benedetto |
  | |
MLTSPNSR | Englebright, Manktelow, Ra, Thiele |
  | |
Add §4909, Ins L; add §4909, Pub Health L | |
  | |
Prohibits a health care plan from making prescription drug formulary changes during a contract year. |
A02969 Actions:
BILL NO | A02969A | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
01/28/2019 | referred to insurance | |||||||||||||||||||||||||||||||||||||||||||||||||
05/21/2019 | reported referred to codes | |||||||||||||||||||||||||||||||||||||||||||||||||
06/04/2019 | reported referred to rules | |||||||||||||||||||||||||||||||||||||||||||||||||
06/05/2019 | reported | |||||||||||||||||||||||||||||||||||||||||||||||||
06/05/2019 | rules report cal.69 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/05/2019 | ordered to third reading rules cal.69 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/06/2019 | amended on third reading 2969a | |||||||||||||||||||||||||||||||||||||||||||||||||
06/17/2019 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
06/17/2019 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
06/17/2019 | REFERRED TO RULES | |||||||||||||||||||||||||||||||||||||||||||||||||
06/19/2019 | SUBSTITUTED FOR S2849A | |||||||||||||||||||||||||||||||||||||||||||||||||
06/19/2019 | 3RD READING CAL.462 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/19/2019 | PASSED SENATE | |||||||||||||||||||||||||||||||||||||||||||||||||
06/19/2019 | RETURNED TO ASSEMBLY | |||||||||||||||||||||||||||||||||||||||||||||||||
12/17/2019 | delivered to governor | |||||||||||||||||||||||||||||||||||||||||||||||||
12/23/2019 | vetoed memo.245 | |||||||||||||||||||||||||||||||||||||||||||||||||
12/23/2019 | tabled |
A02969 Committee Votes:
Cahill | Aye | Garbarino | Aye | ||||||
Cook | Aye | Hawley | Aye | ||||||
Pretlow | Aye | Blankenbush | Aye | ||||||
Rivera | Excused | Finch | Aye | ||||||
Cymbrowitz | Aye | Raia | Aye | ||||||
Lavine | Aye | Palmesano | Aye | ||||||
Steck | Aye | Byrne | Aye | ||||||
Dilan | Aye | ||||||||
Hunter | Aye | ||||||||
Simotas | Aye | ||||||||
Walker | Aye | ||||||||
Niou | Aye | ||||||||
Rosenthal | Aye | ||||||||
Stern | Aye | ||||||||
McDonald | Aye | ||||||||
Romeo | Aye | ||||||||
Jacobson | Aye | ||||||||
Lentol | Aye | Ra | Aye | ||||||
Schimminger | Aye | Giglio | Aye | ||||||
Pretlow | Aye | Montesano | Aye | ||||||
Cook | Aye | Morinello | Aye | ||||||
Cymbrowitz | Aye | Palumbo | Aye | ||||||
O'Donnell | Aye | Garbarino | Aye | ||||||
Lavine | Aye | ||||||||
Perry | Aye | ||||||||
Zebrowski | Aye | ||||||||
Abinanti | Aye | ||||||||
Weprin | Aye | ||||||||
Mosley | Aye | ||||||||
Hevesi | Aye | ||||||||
Fahy | Aye | ||||||||
Seawright | Aye | ||||||||
Rosenthal | Aye | ||||||||
Heastie | Excused | Kolb | Aye | ||||||
Gottfried | Aye | Crouch | Aye | ||||||
Lentol | Aye | Finch | Aye | ||||||
Gantt | Excused | Barclay | Aye | ||||||
Nolan | Excused | Raia | Aye | ||||||
Weinstein | Aye | Hawley | Aye | ||||||
Ortiz | Aye | Giglio | Aye | ||||||
Pretlow | Aye | Malliotakis | Aye | ||||||
Cook | Aye | ||||||||
Glick | Aye | ||||||||
Aubry | Aye | ||||||||
Englebright | Aye | ||||||||
Dinowitz | Aye | ||||||||
Colton | Aye | ||||||||
Magnarelli | Aye | ||||||||
Perry | Aye | ||||||||
Paulin | Excused | ||||||||
Titus | Aye | ||||||||
Peoples-Stokes | Aye | ||||||||
Benedetto | Aye | ||||||||
Lavine | Aye | ||||||||
Lupardo | Aye | ||||||||
Zebrowski | Aye | ||||||||
Go to top
A02969 Floor Votes:
Yes
Abbate
Yes
Crespo
ER
Gantt
Yes
LiPetri
Yes
Perry
Yes
Simon
Yes
Abinanti
Yes
Crouch
Yes
Garbarino
Yes
Lupardo
Yes
Pheffer Amato
Yes
Simotas
Yes
Arroyo
Yes
Cruz
Yes
Giglio
Yes
Magnarelli
Yes
Pichardo
Yes
Smith
Yes
Ashby
Yes
Cusick
Yes
Glick
Yes
Malliotakis
Yes
Pretlow
Yes
Smullen
Yes
Aubry
Yes
Cymbrowitz
Yes
Goodell
Yes
Manktelow
Yes
Quart
Yes
Solages
Yes
Barclay
Yes
Davila
Yes
Gottfried
No
McDonald
Yes
Ra
Yes
Stec
Yes
Barnwell
Yes
De La Rosa
Yes
Griffin
Yes
McDonough
Yes
Raia
Yes
Steck
Yes
Barrett
Yes
DenDekker
Yes
Gunther
Yes
McMahon
Yes
Ramos
Yes
Stern
Yes
Barron
Yes
DeStefano
Yes
Hawley
Yes
Mikulin
Yes
Raynor
Yes
Stirpe
Yes
Benedetto
Yes
Dickens
Yes
Hevesi
Yes
Miller B
Yes
Reilly
Yes
Tague
Yes
Bichotte
Yes
Dilan
Yes
Hunter
Yes
Miller MG
Yes
Reyes
Yes
Taylor
Yes
Blake
Yes
Dinowitz
Yes
Hyndman
Yes
Miller ML
Yes
Richardson
Yes
Thiele
Yes
Blankenbush
Yes
DiPietro
Yes
Jacobson
Yes
Montesano
Yes
Rivera
ER
Titus
Yes
Brabenec
Yes
D'Urso
Yes
Jaffee
Yes
Morinello
Yes
Rodriguez
Yes
Vanel
Yes
Braunstein
Yes
Eichenstein
Yes
Jean-Pierre
Yes
Mosley
Yes
Romeo
Yes
Walczyk
Yes
Bronson
Yes
Englebright
Yes
Johns
Yes
Niou
Yes
Rosenthal D
Yes
Walker
Yes
Buchwald
Yes
Epstein
Yes
Jones
Yes
Nolan
Yes
Rosenthal L
Yes
Wallace
Yes
Burke
Yes
Fahy
Yes
Joyner
Yes
Norris
Yes
Rozic
Yes
Walsh
Yes
Buttenschon
Yes
Fall
Yes
Kim
Yes
O'Donnell
Yes
Ryan
Yes
Weinstein
Yes
Byrne
Yes
Fernandez
Yes
Kolb
Yes
Ortiz
Yes
Salka
Yes
Weprin
Yes
Byrnes
Yes
Finch
Yes
Lalor
Yes
Otis
Yes
Santabarbara
Yes
Williams
Yes
Cahill
Yes
Fitzpatrick
Yes
Lavine
Yes
Palmesano
Yes
Sayegh
Yes
Woerner
Yes
Carroll
Yes
Friend
Yes
Lawrence
Yes
Palumbo
Yes
Schimminger
Yes
Wright
Yes
Colton
Yes
Frontus
Yes
Lentol
Yes
Paulin
Yes
Schmitt
ER
Zebrowski
Yes
Cook
Yes
Galef
Yes
Lifton
Yes
Peoples-Stokes
Yes
Seawright
Yes
Mr. Speaker
‡ Indicates voting via videoconference
A02969 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 2969--A R. R. 69 2019-2020 Regular Sessions IN ASSEMBLY January 28, 2019 ___________ Introduced by M. of A. PEOPLES-STOKES, BARRETT, NIOU, ORTIZ, GALEF, ABINANTI, LAVINE, COLTON, JEAN-PIERRE, TAYLOR, BYRNE, WEPRIN, SEAWRIGHT, BARRON, MOSLEY, LUPARDO, ASHBY, REYES, L. ROSENTHAL, VANEL, STIRPE, D. ROSENTHAL, GRIFFIN, JAFFEE, BUCHWALD, GOTTFRIED, D'URSO, MAGNARELLI, STERN, HUNTER, JACOBSON, LiPETRI, HEVESI, OTIS, CARROLL, STECK, SIMON, MIKULIN, PICHARDO, EPSTEIN, ROZIC, WALLACE, MALLIOTAKIS, BUTTENSCHON, SCHMITT -- Multi-Sponsored by -- M. of A. ENGLEBRIGHT, RA, THIELE -- read once and referred to the Committee on Insurance -- reported and referred to the Committee on Codes -- reported and referred to the Committee on Rules -- amended on the special order of third reading, ordered reprinted as amended, retaining its place on the special order of third reading AN ACT to amend the insurance law and the public health law, in relation to prescription drug formulary changes during a contract year The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The insurance law is amended by adding a new section 4909 2 to read as follows: 3 § 4909. Prescription drug formulary changes. (a) Except as otherwise 4 provided in subsection (c) of this section, a health care plan shall 5 not: 6 (i) remove a prescription drug from a formulary; 7 (ii) move a prescription drug to a tier with a larger deductible, 8 copayment, or coinsurance if the formulary includes two or more tiers of 9 benefits providing for different deductibles, copayments or coinsurance 10 applicable to the prescription drugs in each tier; or 11 (iii) add utilization management restrictions to a prescription drug 12 on a formulary, unless such changes occur at the time of enrollment or 13 issuance of coverage. 14 (b) Prohibitions provided in subsection (a) of this section shall 15 apply beginning on the date on which open enrollment begins for a plan EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD04720-04-9A. 2969--A 2 1 year and through the end of the plan year to which such open enrollment 2 period applies. 3 (c) (i) A health care plan with a formulary that includes two or more 4 tiers of benefits providing for different deductibles, copayments or 5 coinsurance applicable to prescription drugs in each tier may move a 6 prescription drug to a tier with a larger deductible, copayment or coin- 7 surance if an AB-rated generic equivalent or interchangeable biological 8 product for such prescription drug is added to the formulary at the same 9 time. 10 (ii) A health care plan may remove a prescription drug from a formu- 11 lary if the federal Food and Drug Administration determines that such 12 prescription drug should be removed from the market, including new 13 utilization management restrictions issued pursuant to federal Food and 14 Drug Administration safety concerns. 15 (d) A health care plan shall provide notice to policyholders of the 16 intent to remove a prescription drug from a formulary or alter deduct- 17 ible, copayment or coinsurance requirements in the upcoming plan year, 18 thirty days prior to the open enrollment period for the consecutive plan 19 year. Such notice of impending formulary and deductible, copayment or 20 coinsurance changes shall also be posted on the plan's online formulary 21 and in any prescription drug finder system that the plan provides to the 22 public. 23 (e) The provisions of this section shall not supersede the terms of a 24 collective bargaining agreement, or the rights of labor representation 25 groups to collectively bargain changes to the formularies. 26 § 2. The public health law is amended by adding a new section 4909 to 27 read as follows: 28 § 4909. Prescription drug formulary changes. 1. Except as otherwise 29 provided in subdivision three of this section, a health care plan shall 30 not: 31 (a) remove a prescription drug from a formulary; 32 (b) move a prescription drug to a tier with a larger deductible, 33 copayment, or coinsurance if the formulary includes two or more tiers of 34 benefits providing for different deductibles, copayments or coinsurance 35 applicable to the prescription drugs in each tier; or 36 (c) add utilization management restrictions to a prescription drug on 37 a formulary, unless such changes occur at the time of enrollment or 38 issuance of coverage. 39 2. Prohibitions provided in subdivision one of this section shall 40 apply beginning on the date on which open enrollment begins for a plan 41 year and through the end of the plan year to which such open enrollment 42 period applies. 43 3. (a) A health care plan with a formulary that includes two or more 44 tiers of benefits providing for different deductibles, copayments or 45 coinsurance applicable to prescription drugs in each tier may move a 46 prescription drug to a tier with a larger deductible, copayment or coin- 47 surance if an AB-rated generic equivalent or interchangeable biological 48 product for such prescription drug is added to the formulary at the same 49 time. 50 (b) A health care plan may remove a prescription drug from a formulary 51 if the federal Food and Drug Administration determines that such 52 prescription drug should be removed from the market, including new 53 utilization management restrictions issued pursuant to federal Food and 54 Drug Administration safety concerns. 55 4. A health care plan shall provide notice to policyholders of the 56 intent to remove a prescription drug from a formulary or alter deduct-A. 2969--A 3 1 ible, copayment or coinsurance requirements in the upcoming plan year, 2 thirty days prior to the open enrollment period for the consecutive plan 3 year. Such notice of impending formulary and deductible, copayment or 4 coinsurance changes shall also be posted on the plan's online formulary 5 and in any prescription drug finder system that the plan provides to the 6 public. 7 5. The provisions of this section shall not supersede the terms of a 8 collective bargaining agreement, or the rights of labor representation 9 groups to collectively bargain changes to the formularies. 10 § 3. This act shall take effect on the sixtieth day after it shall 11 have become a law. Effective immediately, the addition, amendment 12 and/or repeal of any rule or regulation necessary for the implementation 13 of this act on its effective date are authorized to be made and 14 completed on or before such effective date.